Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Merck & Co., Inc.
  6. News
  7. Summary
    MRK   US58933Y1055

MERCK & CO., INC.

(MRK)
  Report
Delayed Nyse  -  04:03 2022-09-27 pm EDT
85.84 USD   -0.39%
09/27Merck & Co.'s Keytruda Wins Four New Approvals in Japan for Cancer Indications
MT
09/27Merck Division Merck Animal Health Closes Minority Investment in LeeO Precision Farming
MT
09/27TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoint Inhibitor Refractory Non-Small Cell Lung Cancer
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
09/27Merck & Co.'s Keytruda Wins Four New Approvals in Japan for Cancer Indications
MT
09/27Merck Division Merck Animal Health Closes Minority Investment in LeeO Precision Farming
MT
09/27TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoin..
AQ
09/27Merck & Co. Unit Buys Minority Stake In LeeO Precision Farming
MT
09/27Merck Says Keytruda Obtains Four New Approvals in Japan
MT
09/27Merck Animal Health Completes Minority Investment in LeeO Precision Farming
BU
09/27Merck's KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in Hi..
BU
09/26TILT Biotherapeutics Ltd Collaborates with Merck & Co., Inc on Immunotherapy Clinical T..
CI
09/23Merck - LYNPARZA Approved in China as First-Line Maintenance Treatment with Bevacizumab..
AQ
09/22Trending : Merck Reports Court Win in Diabetes Patent Lawsuit Against Viatris
DJ
09/22Merck Boosts Animal-Health Line With Virtual-Fence-Firm Vence
DJ
09/22Merck's Animal Health Unit to Acquire Vence From Founders and Shareholders
MT
09/22Merck Animal Health to Acquire Vence
BU
09/22Merck Says it Received Favorable Court Ruling in Patent Lawsuit Against Viatris
MT
09/22LYNPARZA® (olaparib) Approved in China as First-Line Maintenance Treatment With Bevaciz..
BU
More most relevant news
All news about MERCK & CO., INC.
09/27Merck & Co.'s Keytruda Wins Four New Approvals in Japan for Cancer Indications
MT
09/27Merck Division Merck Animal Health Closes Minority Investment in LeeO Precision Farming
MT
09/27TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoin..
AQ
09/27ETF Preview: ETFs, Futures Bounce Pre-Bell After Recession Fears Prompted Se..
MT
09/27Merck & Co. Unit Buys Minority Stake In LeeO Precision Farming
MT
09/27Merck Says Keytruda Obtains Four New Approvals in Japan
MT
09/27Merck Animal Health Completes Minority Investment in LeeO Precision Farming
BU
09/27Merck's KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in Hi..
BU
09/27AstraZeneca-Merck's Rare Genetic Condition Medicine Gets Approval in Japan
MT
09/26TILT Biotherapeutics Ltd Collaborates with Merck & Co., Inc on Immunotherapy Clinical T..
CI
More news
News in other languages on MERCK & CO., INC.
09/27Keytruda de Merck & Co. obtient quatre nouvelles approbations au Japon pour des indicat..
09/27La division Merck de Merck Animal Health conclut un investissement minoritaire dans Lee..
09/27Merck : quatre nouvelles approbations pour Keytruda au Japon
09/27Aperçu des ETF : Les ETF et les contrats à terme rebondissent avant la cl..
09/27Une unité de Merck & Co. achète une participation minoritaire dans LeeO Precision Farmi..
09/27Merck déclare que Keytruda a obtenu quatre nouvelles approbations au Japon
09/26ANALYSEN DES TAGES von Dow Jones Newswires (26.09.2022)
09/26TILT Biotherapeutics Ltd collabore avec Merck & Co., Inc sur un essai clinique d'immuno..
09/23Merck : remporte la 1ère bataille judiciaire pour ses brevets
09/22Les actions américaines terminent en baisse jeudi malgré des gains dans le secteur de l..
More news
Analyst Recommendations on MERCK & CO., INC.
09/14Merck & Co. Rises After Berenberg Upgrade
MT
09/14Berenberg Bank Upgrades Merck to Buy From Hold, Adjusts Price Target to $100 From $95
MT
09/12SVB Securities LLC Raises Merck & Company's Price Target to $109 From $105, Keeps Outpe..
MT
08/16Seagen Upgraded by RBC to Outperform From Sector Perform, Price Target Raised to $188 F..
MT
08/01UBS Adjusts Merck & Company Price Target to $97 From $98, Maintains Neutral Rating
MT
More recommendations
Press releases
09/27TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoin..
AQ
09/27Merck Animal Health Completes Minority Investment in LeeO Precision Farming
BU
09/27Merck's KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in Hi..
BU
09/23Merck - LYNPARZA Approved in China as First-Line Maintenance Treatment with Bevacizumab..
AQ
09/22Merck Animal Health to Acquire Vence
BU
More press releases
Analysis
Pharmaceutical companies still have the upper hand
Stock Pick
 MERCK & CO., INC.
A cash cow that hides some gems
Official Publications
07/28Slide show half-year results 
07/281st-half-year results 
07/28SEC Filing 8K 
07/26Dividends 
05/24Dividends 
05/05SEC Filing 10Q-1 
Upcoming event on MERCK & CO., INC.
10/27/22Q3 2022 Earnings Call
Upcoming sector events
10/18/22JOHNSON & JOHNSON : Q3 2022 Earnings Release
11/01/22PFIZER INC. : Q3 2022 Earnings Release
11/01/22ELI LILLY AND COMPANY : Q3 2022 Earnings Release
11/04/22ABBVIE INC. : Q3 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals